INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23P19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS"

GENEVA, March 25 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/046081) for "PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23p19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS" on Sep 12, 2025. With publication no. WO/2026/060205, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOWNING, AnnCatherine M. (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), LIM, Joel (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), P...